Thula and ASSA Abloy UK Announce Strategic Partnership at CPC North 2023

Thula is delighted to announce an exciting collaboration with ASSA Abloy UK. This strategic partnership promises to revolutionise the way discrepancies are investigated in the management of controlled drugs.

The main goal is to utilise Abloy’s innovative CLIQ system and seamlessly connect it with Thula’s Alfa system, enabling the querying of CLIQ data, to provide users with a more comprehensive and sophisticated audit trail. This enhanced audit trail will be invaluable when addressing controlled drug-related discrepancies. This level of insight and control will allow healthcare professionals to make more informed decisions, ensure compliance, and improve overall operations.

Magnús Kristjánsson, Thula´s CEO, shares:

"We are thrilled to embark on this partnership with ASSA Abloy UK. By combining our expertise and innovative solutions, we are confident that we will set new industry standards for controlled drug management. This partnership marks a significant milestone, promising enhanced functionality, improved transparency, and greater efficiency in addressing discrepancies."

For more information on Thula's partners and products, please visit: www.thula.uk